Evidence map›Paper›PMID 37982066›Full record

ArticleDiabetes spectrum : a publication of the American Diabetes Association2023

Roadmap to the Effective Use of Continuous Glucose Monitoring in Primary Care.

Thomas W Martens

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Diabetes spectrum : a publication of the American Diabetes Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07394075 (Translating Continuous Glucose Monitoring), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07394075 enrolling by invitationnot on this mapstarted 2026, after this paper: background citation

Translating Continuous Glucose Monitoring (CGM) Data Into Action to Improve Management of Insulin-Treated T2D in Primary Care

TypeobservationalSponsorHealthPartners InstituteRan2026 to 2028Enrolled150ConditionsType 2 DiabetesArmsContinuous Glucose Monitoring Clinical Decision Support
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Roadmaps to Continuous Glucose Monitoring's Role in Transforming Diabetes Management.Diabetes spectrum : a publication of the American Diabetes Association · 2023
    Article
  8. Roadmap to the Effective Use of Continuous Glucose Monitoring: Innovation, Investigation, and Implementation.Diabetes spectrum : a publication of the American Diabetes Association · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Thomas W MartensInternational Diabetes Center and Park Nicollet Department of Internal Medicine, St. Louis Park, MN.ORCID https://orcid.org/0000-0002-9858-2138
Park Nicollet Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes technology has undergone a remarkable evolution in the past decade, with dramatic improvements in accuracy and ease of use. Continuous glucose monitor (CGM) technology, in particular, has evolved, and coevolved with widely available consumer smartphone technology, to provide a unique opportunity to both improve management and decrease the burden of management for populations across nearly the entire spectrum of people living with diabetes. Capitalizing on that opportunity, however, will require both adoption of and adaptations to the use of CGM technology in the broader world of primary care. This article focuses on mechanisms to expand pathways to optimized glycemic management, thereby creating a robust roadway capable of improving care across broad populations managed in primary care settings. Recent expansions in access to devices combined with improved mechanisms for data access at the time of primary care visits and improved training and evolving systems of support within primary care, hold potential to improve glycemic management in diabetes across the health care spectrum.

Identifiers

PMID37982066
PMCPMC10654126
OpenAlexW4388691496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.